Efficacy and safety of Ruxolitinib, Crisaborole, and Tapinarof for mild-to-moderate atopic dermatitis: a Bayesian network analysis of RCTs
Xuechen Cao, Jiawei Lu, Yifei Feng, Lebin Song, Yan Lü
Topics & Concepts
MedicineAtopic dermatitisInternal medicineRandomized controlled trialEczema Area and Severity IndexRuxolitinibClinical trialConfidence intervalOdds ratioDermatologyMyelofibrosisBone marrowDermatology and Skin DiseasesAllergic Rhinitis and SensitizationAsthma and respiratory diseases